AgelessRx

AgelessRx Science-backed longevity care, made simple. A portion of every purchase supports longevity research, helping drive the future of age-defying healthcare.

AgelessRx is a first-of-its-kind telehealth platform for longevity, delivering personalized, science-backed care that targets aging at its root. From prescription therapies to ongoing clinical support, our mission is to make expert-guided, preventative care accessible, empowering more people to take control of their healthspan to live healthier, longer lives.

09/03/2026

For Dr. Robert Dudley, this competition isn't just about the science. It's about what the science makes possible. XPRIZE Healthspan empowers researchers to run studies that go beyond a number on a lab report. The goal: helping patients feel measurably better, with more energy for the years and people that matter most to them.

Helping others has been the throughline of his entire career. This is just the latest chapter.

We're proud to be part of research aimed at real, lived impact, not just data points.

(For educational purposes only)

Muscle loss on GLP-1s gets blamed on the drug. A new mouse study suggests that's not the full story.Obese mice were give...
09/02/2026

Muscle loss on GLP-1s gets blamed on the drug. A new mouse study suggests that's not the full story.

Obese mice were given Semaglutide alone or Semaglutide plus ketone esters for 3 weeks. The Semaglutide-only group lost about 55% of body weight, but also lost roughly 9 grams of muscle, along with signs of muscle atrophy including reduced strength and altered gene expression. The group that also received ketone esters lost less weight overall, about 36%, but lost only around 3 grams of muscle, with no meaningful difference in fat loss between groups. That's roughly 67% less muscle loss for a similar reduction in fat.

This points to something important: the muscle loss often associated with GLP-1s may not be about the medication itself. It may be about how the body handles a steep, unsupported calorie deficit, something that can happen with any rapid weight loss, GLP-1 or not.

A few caveats worth naming. This is a mouse study, and fat metabolism differs meaningfully between mice and humans. The weight loss here was also rapid and extreme, with high daily doses of both Semaglutide and ketone esters, not the gradual titration typically used in practice. This is hypothesis-generating, not conclusive.

What is well established: adequate protein intake and resistance training remain essential tools for preserving muscle during any significant weight loss.

Read the full breakdown. Link in bio.

(For educational purposes only)

Peptides are everywhere right now, but most of the buzz isn't backed by much data.Many trending peptides have little to ...
08/31/2026

Peptides are everywhere right now, but most of the buzz isn't backed by much data.

Many trending peptides have little to no human clinical research behind them. PT-141 is different. It's been studied in humans since the early 2000s, with decades of clinical history and an FDA approval behind it.

That history matters. Years of trials tell a very different story than a trending post, and most of that research predates the current peptide wave entirely. This isn't a new discovery riding a trend. It's an established one getting new attention.

When you're looking at any peptide, the real question isn't how popular it is. It's how much research stands behind it.

See the research behind it. Link in bio.

(For educational purposes only)

08/29/2026

Can a peptide really change how we think about intimacy?

In two major randomized, placebo-controlled clinical trials, women with hypoactive sexual desire disorder took PT-141 and saw measurable changes across multiple validated measures, not just self-reported mood. Desire scores rose significantly on the Female Sexual Function Index, and distress scores dropped significantly on the Female Sexual Distress Scale, both compared to placebo.

Using a responder analysis, a method that defines a clinically meaningful threshold rather than just averaging scores, 58% of women taking PT-141 showed a meaningful improvement in desire, compared to 36% on placebo.

That gap matters. PT-141 doesn't work like most people assume. It acts directly on melanocortin receptors in the brain, specifically MC4R, to influence the neural pathways behind desire and motivation, rather than working on blood flow the way other treatments do.

Learn more about PT-141 at the link in bio.

(For educational purposes only)

08/27/2026

AgelessRx is one of 10 finalist teams selected out of nearly 800 to compete in the XPRIZE Healthspan finals.

This isn't just a competition to us. It's an opportunity to prove that decline isn't the default setting of aging.

For too long, we've watched the people we love fade and assumed that's just what getting older looks like. We don't accept that. XPRIZE Healthspan gives us the platform to run the kind of research that could change what aging actually means, not just adding years to a lifespan, but adding life to those years.

This is what we've been working toward. And we're just getting started.

(For educational purposes only)

Check your biomarkers before something’s wrong. Treat your annual bloodwork like it’s just as important as any other app...
08/25/2026

Check your biomarkers before something’s wrong. Treat your annual bloodwork like it’s just as important as any other appointment on your calendar. Prioritize your health instead of waiting for a wake-up call.

The healthiest people we know aren’t reactive. They’re not waiting for a diagnosis to start paying attention. They’re tracking, testing, and making decisions based on data, not guesswork.

Your longevity plan should be as intentional as everything else in your routine.

(For educational purposes only)

We were featured in NPR this week for something the longevity world has been paying close attention to.The piece explore...
08/24/2026

We were featured in NPR this week for something the longevity world has been paying close attention to.

The piece explores tadalafil, better known as Cialis, and the growing body of research suggesting it may have meaningful benefits well beyond its original indication. An analysis of more than 8,000 men taking tadalafil found a 55% lower rate of dying from cardiovascular causes and a 44% lower rate of overall mortality during the study period. A separate study drawing on more than half a million patients showed a 32% lower risk of dementia among those taking the drug. The findings are observational, and researchers are careful to note that randomized trials are still needed, but the signal across the literature is remarkably consistent.

AgelessRx Medical Director Dr. Jenell Decker was interviewed for the piece, speaking to why the existing data is strong enough to warrant offering low dose tadalafil to both men and women over 40 for longevity purposes. In longevity medicine, waiting for perfect data often means waiting until someone is already behind. The prevention window matters, and acting within it is the entire point.

The Princeton Consensus Panel, an influential group of preventive cardiologists and men’s health experts, recently arrived at consensus language that low dose tadalafil is appropriate for a subset of men at elevated cardiovascular risk, a signal that this conversation is moving beyond wellness circles and into mainstream clinical medicine.

We are proud to be part of a conversation that is pushing longevity science forward in a serious and evidence-informed way.

Read the full NPR article at the link in bio.

(For educational purposes only)

We were featured in NPR this week for something the longevity world has been paying close attention to.The piece explore...
08/24/2026

We were featured in NPR this week for something the longevity world has been paying close attention to.

The piece explores tadalafil, better known as Cialis, and the growing body of research suggesting it may have meaningful benefits well beyond its original indication. An analysis of more than 8,000 men taking tadalafil found a 55% lower rate of dying from cardiovascular causes and a 44% lower rate of overall mortality during the study period. A separate study drawing on more than half a million patients showed a 32% lower risk of dementia among those taking the drug. The findings are observational, and researchers are careful to note that randomized trials are still needed, but the signal across the literature is remarkably consistent.

AgelessRx Medical Director Dr. Jenell Decker was interviewed for the piece, speaking to why the existing data is strong enough to warrant offering low dose tadalafil to both men and women over 40 for longevity purposes. In longevity medicine, waiting for perfect data often means waiting until someone is already behind. The prevention window matters, and acting within it is the entire point.

The Princeton Consensus Panel, an influential group of preventive cardiologists and men's health experts, recently arrived at consensus language that low dose tadalafil is appropriate for a subset of men at elevated cardiovascular risk, a signal that this conversation is moving beyond wellness circles and into mainstream clinical medicine.

We are proud to be part of a conversation that is pushing longevity science forward in a serious and evidence-informed way.

Read the full NPR article at the link in bio.

(For educational purposes only)

08/21/2026

No one warns you that desire can change during menopause too.

Most conversations stop at hot flashes and sleep. But desire has real biological drivers, and menopause affects several of them at once. Estrogen decline during perimenopause and menopause impacts brain regions tied to arousal and motivation, along with ge***al blood flow. Testosterone, which women also produce and which plays a direct role in desire, naturally declines with age too. On top of that, dopamine activity, the neurotransmitter most linked to wanting and motivation, can shift as hormone levels change.

Put together, it's not surprising that desire moves during this transition. It's biology responding to real changes, not a personal failing.

This is common. It's just rarely said out loud.

Ready to learn more? Link in bio.

(For educational purposes only)

We are proud to share that our research team has been named XPRIZE Healthspan Finalists.XPRIZE Healthspan is one of the ...
08/19/2026

We are proud to share that our research team has been named XPRIZE Healthspan Finalists.

XPRIZE Healthspan is one of the most competitive and ambitious scientific challenges in the world, calling on leading researchers to develop interventions that measurably reverse the effects of aging. Being recognized as finalists places AgelessRx among a select group of teams pushing the boundaries of what longevity science can actually do.

Congratulations to our research team, and thank you for representing AgelessRx on one of the biggest stages in longevity science.

Address

Ann Arbor, MI

Opening Hours

Monday 9am - 6pm
Tuesday 9am - 6pm
Wednesday 9am - 6pm
Thursday 9am - 6pm
Friday 9am - 6pm

Website

Alerts

Be the first to know and let us send you an email when AgelessRx posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to AgelessRx:

Shortcuts

Share